Nanotechnology for Age-Related Macular Degeneration

Age-related macular degeneration (AMD) is a degenerative eye disease that is the leading cause of irreversible vision loss in people 50 years and older. Today, the most common treatment for AMD involves repeated intravitreal injections of anti-vascular endothelial growth factor (VEGF) drugs. However...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Bo, Li, Ge, Liu, Jiaxin, Li, Xiangyu, Zhang, Shixin, Sun, Fengying, Liu, Wenhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8705006/
https://www.ncbi.nlm.nih.gov/pubmed/34959316
http://dx.doi.org/10.3390/pharmaceutics13122035

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8705006/
https://www.ncbi.nlm.nih.gov/pubmed/34959316
http://dx.doi.org/10.3390/pharmaceutics13122035

Ejemplares similares